From Diagnosis to Treatment : Clinical Applications of Nanotechnology in Thoracic Surgery - 25/04/16

Résumé |
Nanotechnology is an emerging field with potential as an adjunct to cancer therapy, particularly thoracic surgery. Therapy can be delivered to tumors in a more targeted fashion, with less systemic toxicity. Nanoparticles may aid in diagnosis, preoperative characterization, and intraoperative localization of thoracic tumors and their lymphatics. Focused research into nanotechnology’s ability to deliver both diagnostics and therapeutics has led to the development of nanotheranostics, which promises to improve the treatment of thoracic malignancies through enhanced tumor targeting, controlled drug delivery, and therapeutic monitoring. This article reviews nanoplatforms, their unique properties, and the potential for clinical application in thoracic surgery
Le texte complet de cet article est disponible en PDF.Keywords : Nanotechnology, Nanotheranostics, Lung cancer, Thoracic surgery
Plan
| This work was supported with funding from the National Science Foundation (DMR-1006601) and the National Institutes of Health (R01CA131044, R01CA149561, R25 CA153955, T32 CA009535). |
|
| The authors have no disclosures. |
|
| This work was supported in part by Brigham and Women’s Hospital Center for Surgical Innovation, Boston University Center for Integration of Medicine and Innovative Technology, Boston University Nanomedicine Program and Cross-Disciplinary Training in Nanotechnology for Cancer, and Brigham and Women’s Hospital Advanced Training in Surgical Oncology. |
Vol 26 - N° 2
P. 215-228 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
